The ending of Biocon's $350 million partnership with Pfizer means Biocon will need to find new partners to realize its growth plans. The deal was seen as validating multinational partnerships with Indian companies, but both companies cited changed priorities for ending it. Biocon retains $200 million from the deal but loses potential payments. It now needs to find a new partner with strong markets in developed countries to access those markets for its insulin products. The termination is a setback for both companies' goals in biosimilars.
India Healthcare and Lifesciences Investment Heatmap 2020 - VC Circle, Kapil ...Kapil Khandelwal (KK)
Our Healthcare and Life Sciences Investment Heatmap for the year 2020 published in VC Circle
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Laying out the 100-day agenda for Modiʼs Healthcare Reform 2.0 : VC Circle, K...Kapil Khandelwal (KK)
The document lays out a 100-day agenda for Modi's second term healthcare reforms. It discusses focusing on encouraging private sector participation through investments in social infrastructure, clinical staff supply chains, and longitudinal research on price controls and innovation. Specific policies and actions are recommended around healthcare infrastructure financing, skills development, and establishing a national research agency for healthcare. The conclusion calls for government-industry dialogue to kickstart investment through strong reform agenda.
The document discusses funding strategies and options for medical technology entrepreneurs. It explains that securing funding is a critical success factor for medical technology ventures to succeed and grow. There are different types of funding available at various stages of a venture. The article provides guidance on putting together an effective funding proposal, including clearly articulating the market opportunity, management team capabilities, and financial plan. It also outlines considerations for raising money from sources like venture capitalists and private equity investors.
Kapil Khandelwal Post Budget Analysis In Modern Medicare Aug 09guest049fe3b
The document discusses fiscal reforms that could be implemented in India to improve healthcare delivery. It suggests several policy measures such as tax holidays for new healthcare infrastructure, increasing tax deductions for medical expenses, and incentivizing preventative health checkups. It also proposes increasing funding for healthcare education and capacity building. Overall the document argues that targeted fiscal policies could help address future health risks and enable better population health outcomes in India.
The ending of Biocon's $350 million partnership with Pfizer means Biocon will need to find new partners to realize its growth plans. The deal was seen as validating multinational partnerships with Indian companies, but both companies cited changed priorities for ending it. Biocon retains $200 million from the deal but loses potential payments. It now needs to find a new partner with strong markets in developed countries to access those markets for its insulin products. The termination is a setback for both companies' goals in biosimilars.
India Healthcare and Lifesciences Investment Heatmap 2020 - VC Circle, Kapil ...Kapil Khandelwal (KK)
Our Healthcare and Life Sciences Investment Heatmap for the year 2020 published in VC Circle
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Laying out the 100-day agenda for Modiʼs Healthcare Reform 2.0 : VC Circle, K...Kapil Khandelwal (KK)
The document lays out a 100-day agenda for Modi's second term healthcare reforms. It discusses focusing on encouraging private sector participation through investments in social infrastructure, clinical staff supply chains, and longitudinal research on price controls and innovation. Specific policies and actions are recommended around healthcare infrastructure financing, skills development, and establishing a national research agency for healthcare. The conclusion calls for government-industry dialogue to kickstart investment through strong reform agenda.
The document discusses funding strategies and options for medical technology entrepreneurs. It explains that securing funding is a critical success factor for medical technology ventures to succeed and grow. There are different types of funding available at various stages of a venture. The article provides guidance on putting together an effective funding proposal, including clearly articulating the market opportunity, management team capabilities, and financial plan. It also outlines considerations for raising money from sources like venture capitalists and private equity investors.
Kapil Khandelwal Post Budget Analysis In Modern Medicare Aug 09guest049fe3b
The document discusses fiscal reforms that could be implemented in India to improve healthcare delivery. It suggests several policy measures such as tax holidays for new healthcare infrastructure, increasing tax deductions for medical expenses, and incentivizing preventative health checkups. It also proposes increasing funding for healthcare education and capacity building. Overall the document argues that targeted fiscal policies could help address future health risks and enable better population health outcomes in India.
From Telegraph Road to US$50 Billion Digital Health Silk Road : Kapil Khandel...Kapil Khandelwal (KK)
India has significant healthcare needs and a large shortage of clinical manpower and infrastructure. The COVID-19 pandemic accelerated the push for healthcare digitization in India. New digital health regulations were announced and the industry estimates digital healthcare could unlock $200-250 billion for the Indian economy over 10 years. However, realizing this potential would require $30 billion in tech investments, which is a major challenge given current investment levels and data/infrastructure constraints in India. Significant capacity building is still needed to develop a truly digital healthcare system at scale.
Healthcare sector update march 2013 ibefbrandsynapse
The document discusses the healthcare market in India. It notes that the healthcare revenue in India is projected to reach $280 billion by 2020, growing at a CAGR of 12% from 2012-2015. Private sector accounts for 68% of total healthcare spending in India in 2011. Key segments of the healthcare market include hospitals, pharmaceuticals, medical equipment and supplies, and medical insurance. Hospitals account for 71% of total healthcare revenues in India. The market is expected to benefit from rising incomes, increasing health awareness, lifestyle diseases, and greater health insurance penetration.
Rightview Partners recommends that Community Health Systems sell itself to Universal Health Services due to CYH's high leverage and the attractive multiples being achieved in the hospital M&A market. An acquisition by UHS could help address CYH's leverage by being an all-equity deal. Alternatively, if CYH wants to grow, Lifepoint Hospitals would be a good acquisition target due to synergies. Valuation analyses show CYH is worth $57.86-$93 per share currently.
The document provides an overview of the healthcare sector in India. Some key points:
- The Indian healthcare sector is expected to grow at a CAGR of 22% until 2022 to reach $372 billion.
- Rising incomes, growing health awareness, lifestyle diseases, and insurance coverage are driving growth in the sector.
- The government aims to increase public health spending to 2.5% of GDP by 2025 and launch programs like Ayushman Bharat to expand coverage.
- Private investment and emerging areas like telemedicine, home healthcare, and medical technology offer opportunities in the growing Indian healthcare industry.
The healthcare sector in India is poised for strong growth driven by rising incomes, greater health awareness, lifestyle diseases, and increasing access to insurance. The sector is expected to reach US$ 372 billion by 2022 from US$ 110 billion in 2016. Private sector investment and M&A activity has increased as the government encourages private sector participation and foreign investment through supportive policies. Growing demand, policy support, focus on technology and R&D, and consolidation in the industry through mergers and acquisitions will be the key growth drivers for the Indian healthcare sector.
The healthcare sector in India is poised for strong growth driven by rising incomes, an aging population, growing health awareness, and policy support. Key factors fueling growth include a growing demand for healthcare services as incomes rise and diseases patterns change. The sector is also attracting significant private sector investments through mergers and acquisitions as well as from foreign players setting up R&D centers and hospitals in India. The government is also encouraging growth in the sector through favorable policies for foreign investment and the private sector as well as programs to expand health insurance coverage and healthcare infrastructure across the country. The sector is expected to reach $372 billion by 2022 from $110 billion in 2016, growing at a 22% CAGR.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
Investment Insurance - Prospects of insurance sector in indiaGaurav Kadam
Investment Insurance policy cum investment insurance plans from Bajaj Allianz that will help you secure your families future and see your investments grow steadily.
https://www.bajajallianz.com/Corp/investment-plans/investment-plans.jsp
The Indian healthcare industry is growing rapidly due to increasing healthcare expenditure by both public and private players. The industry is expected to reach $280 billion by 2022, registering a 22.9% compound annual growth rate from 2015-2022. The private sector accounts for about 74% of total healthcare spending in India. The government aims to develop India as a global healthcare hub by increasing access through initiatives like the National Health Mission and encouraging private sector growth. Key drivers of growth include rising incomes, greater health awareness, lifestyle diseases, and health insurance expansion.
Indian healthcare sector is expected to grow threefold to reach $372 billion by 2022. Rising incomes, growing health awareness, and increasing access to insurance are driving growth of the sector. The sector employs over 319,000 people and is expected to generate 40 million jobs by 2020. Telemedicine is emerging as a key trend, with major hospitals adopting telemedicine services to bridge rural-urban healthcare divides. The sector is also expanding to tier 2 and 3 cities. Lifestyle diseases have replaced traditional health problems as the major cause of healthcare spending in India.
Indian healthcare sector is expected to grow significantly over the next decade to reach US$372 billion by 2022. Key growth drivers include rising incomes, greater health awareness and demand for quality services. Healthcare infrastructure has also expanded rapidly with the number of doctors and medical colleges increasing. Notable trends in the sector include the emergence of telemedicine, expansion of services to tier-2 and tier-3 cities, and a shift from communicable to lifestyle diseases. The government aims to increase healthcare spending and develop India as a global healthcare hub through various initiatives.
Scope of Healthcare Investments in India for International Venture CapitalistsDr. Varun Goyal
As the Healthcare industry in India is in boom, there is a lot of opportunities for Investors to make healthy investments in Indian Healthcare Industry.
India must refocus at the core domestic economic fundamentalsIndiastat .com
- Pramod Bhasin, Chairman of ICRIER, believes India must refocus on core domestic economic fundamentals like synchronized foreign trade, FDI, digital, skills, and job policies to boost its COVID-19 impacted economy.
- He recommends using data and technology as tools to capture real-time sectoral data and build platforms to help address issues.
- India needs to improve its health and education infrastructure, conduct risk mapping of the informal sector, and prioritize sectors like agriculture, pharmaceuticals, healthcare, startups, and digital to achieve its $5 trillion economy goal and speed economic growth post-pandemic.
ASEAN shows a strong growth of health expenditure per capita leading by Singapore, Malaysia and Thailand. To find out more about other countries, check out our latest publication at http://bit.ly/1hmvwFq
MTBiz is for you if you are looking for contemporary information on business, economy and especially on banking industry of Bangladesh. You would also find periodical information on Global Economy and Commodity Markets.
Business of disasters - Kapil Khandelwal - www.kapilkhandelwal.comKapil Khandelwal (KK)
my monthly column on Disaster Management. Business can sustain on disasters rather than let politician do what they can in disasters. #Uttarakhand
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Most fastest growing pharmaceutical companies in 2021Swiftnlift
Over the past two decades, the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centres, and the medical profession itself.
The document provides an overview of the healthcare sector in India. Some key points:
- The Indian healthcare sector is expected to grow at a CAGR of 22% from 2016-2022 to reach $372 billion.
- Rising incomes, growing health awareness, and increasing access to insurance are driving growth in healthcare spending.
- Private sector participation is strong, accounting for around 74% of total healthcare expenditure.
- Government initiatives like increased FDI, tax benefits, and developing India as a medical tourism hub are supporting industry growth.
- Emerging trends include a shift to lifestyle diseases, expansion to tier 2/3 cities, growing telemedicine and home healthcare markets.
The document summarizes corporate earnings growth in the second quarter of 2019. Earnings growth of 1.74% and sales growth of 3.62% were a surprise to the upside as growth was expected to be slightly negative. Earnings beat expectations by 5% while sales topped expectations by 0.5%. While growth has slowed, companies have generally outperformed expectations with stable underlying profit trends. Future expectations point to a potential return to positive earnings growth after a projected slight decline in the next quarter.
The document summarizes a market perspectives report from February 2019. It notes that while corporate earnings continued to rebound in Q4 2018 with sales and earnings growth, concerns about future growth have emerged given global market volatility and more difficult year-over-year comparisons as companies will no longer benefit from tax cuts that boosted 2018 growth. The report analyzes recent earnings trends and expectations for slowing but continued growth in 2019, noting that earnings slowdowns do not always predict recessions and some slowing may already be priced into market expectations given valuation levels.
From Telegraph Road to US$50 Billion Digital Health Silk Road : Kapil Khandel...Kapil Khandelwal (KK)
India has significant healthcare needs and a large shortage of clinical manpower and infrastructure. The COVID-19 pandemic accelerated the push for healthcare digitization in India. New digital health regulations were announced and the industry estimates digital healthcare could unlock $200-250 billion for the Indian economy over 10 years. However, realizing this potential would require $30 billion in tech investments, which is a major challenge given current investment levels and data/infrastructure constraints in India. Significant capacity building is still needed to develop a truly digital healthcare system at scale.
Healthcare sector update march 2013 ibefbrandsynapse
The document discusses the healthcare market in India. It notes that the healthcare revenue in India is projected to reach $280 billion by 2020, growing at a CAGR of 12% from 2012-2015. Private sector accounts for 68% of total healthcare spending in India in 2011. Key segments of the healthcare market include hospitals, pharmaceuticals, medical equipment and supplies, and medical insurance. Hospitals account for 71% of total healthcare revenues in India. The market is expected to benefit from rising incomes, increasing health awareness, lifestyle diseases, and greater health insurance penetration.
Rightview Partners recommends that Community Health Systems sell itself to Universal Health Services due to CYH's high leverage and the attractive multiples being achieved in the hospital M&A market. An acquisition by UHS could help address CYH's leverage by being an all-equity deal. Alternatively, if CYH wants to grow, Lifepoint Hospitals would be a good acquisition target due to synergies. Valuation analyses show CYH is worth $57.86-$93 per share currently.
The document provides an overview of the healthcare sector in India. Some key points:
- The Indian healthcare sector is expected to grow at a CAGR of 22% until 2022 to reach $372 billion.
- Rising incomes, growing health awareness, lifestyle diseases, and insurance coverage are driving growth in the sector.
- The government aims to increase public health spending to 2.5% of GDP by 2025 and launch programs like Ayushman Bharat to expand coverage.
- Private investment and emerging areas like telemedicine, home healthcare, and medical technology offer opportunities in the growing Indian healthcare industry.
The healthcare sector in India is poised for strong growth driven by rising incomes, greater health awareness, lifestyle diseases, and increasing access to insurance. The sector is expected to reach US$ 372 billion by 2022 from US$ 110 billion in 2016. Private sector investment and M&A activity has increased as the government encourages private sector participation and foreign investment through supportive policies. Growing demand, policy support, focus on technology and R&D, and consolidation in the industry through mergers and acquisitions will be the key growth drivers for the Indian healthcare sector.
The healthcare sector in India is poised for strong growth driven by rising incomes, an aging population, growing health awareness, and policy support. Key factors fueling growth include a growing demand for healthcare services as incomes rise and diseases patterns change. The sector is also attracting significant private sector investments through mergers and acquisitions as well as from foreign players setting up R&D centers and hospitals in India. The government is also encouraging growth in the sector through favorable policies for foreign investment and the private sector as well as programs to expand health insurance coverage and healthcare infrastructure across the country. The sector is expected to reach $372 billion by 2022 from $110 billion in 2016, growing at a 22% CAGR.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
Investment Insurance - Prospects of insurance sector in indiaGaurav Kadam
Investment Insurance policy cum investment insurance plans from Bajaj Allianz that will help you secure your families future and see your investments grow steadily.
https://www.bajajallianz.com/Corp/investment-plans/investment-plans.jsp
The Indian healthcare industry is growing rapidly due to increasing healthcare expenditure by both public and private players. The industry is expected to reach $280 billion by 2022, registering a 22.9% compound annual growth rate from 2015-2022. The private sector accounts for about 74% of total healthcare spending in India. The government aims to develop India as a global healthcare hub by increasing access through initiatives like the National Health Mission and encouraging private sector growth. Key drivers of growth include rising incomes, greater health awareness, lifestyle diseases, and health insurance expansion.
Indian healthcare sector is expected to grow threefold to reach $372 billion by 2022. Rising incomes, growing health awareness, and increasing access to insurance are driving growth of the sector. The sector employs over 319,000 people and is expected to generate 40 million jobs by 2020. Telemedicine is emerging as a key trend, with major hospitals adopting telemedicine services to bridge rural-urban healthcare divides. The sector is also expanding to tier 2 and 3 cities. Lifestyle diseases have replaced traditional health problems as the major cause of healthcare spending in India.
Indian healthcare sector is expected to grow significantly over the next decade to reach US$372 billion by 2022. Key growth drivers include rising incomes, greater health awareness and demand for quality services. Healthcare infrastructure has also expanded rapidly with the number of doctors and medical colleges increasing. Notable trends in the sector include the emergence of telemedicine, expansion of services to tier-2 and tier-3 cities, and a shift from communicable to lifestyle diseases. The government aims to increase healthcare spending and develop India as a global healthcare hub through various initiatives.
Scope of Healthcare Investments in India for International Venture CapitalistsDr. Varun Goyal
As the Healthcare industry in India is in boom, there is a lot of opportunities for Investors to make healthy investments in Indian Healthcare Industry.
India must refocus at the core domestic economic fundamentalsIndiastat .com
- Pramod Bhasin, Chairman of ICRIER, believes India must refocus on core domestic economic fundamentals like synchronized foreign trade, FDI, digital, skills, and job policies to boost its COVID-19 impacted economy.
- He recommends using data and technology as tools to capture real-time sectoral data and build platforms to help address issues.
- India needs to improve its health and education infrastructure, conduct risk mapping of the informal sector, and prioritize sectors like agriculture, pharmaceuticals, healthcare, startups, and digital to achieve its $5 trillion economy goal and speed economic growth post-pandemic.
ASEAN shows a strong growth of health expenditure per capita leading by Singapore, Malaysia and Thailand. To find out more about other countries, check out our latest publication at http://bit.ly/1hmvwFq
MTBiz is for you if you are looking for contemporary information on business, economy and especially on banking industry of Bangladesh. You would also find periodical information on Global Economy and Commodity Markets.
Business of disasters - Kapil Khandelwal - www.kapilkhandelwal.comKapil Khandelwal (KK)
my monthly column on Disaster Management. Business can sustain on disasters rather than let politician do what they can in disasters. #Uttarakhand
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Most fastest growing pharmaceutical companies in 2021Swiftnlift
Over the past two decades, the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centres, and the medical profession itself.
The document provides an overview of the healthcare sector in India. Some key points:
- The Indian healthcare sector is expected to grow at a CAGR of 22% from 2016-2022 to reach $372 billion.
- Rising incomes, growing health awareness, and increasing access to insurance are driving growth in healthcare spending.
- Private sector participation is strong, accounting for around 74% of total healthcare expenditure.
- Government initiatives like increased FDI, tax benefits, and developing India as a medical tourism hub are supporting industry growth.
- Emerging trends include a shift to lifestyle diseases, expansion to tier 2/3 cities, growing telemedicine and home healthcare markets.
The document summarizes corporate earnings growth in the second quarter of 2019. Earnings growth of 1.74% and sales growth of 3.62% were a surprise to the upside as growth was expected to be slightly negative. Earnings beat expectations by 5% while sales topped expectations by 0.5%. While growth has slowed, companies have generally outperformed expectations with stable underlying profit trends. Future expectations point to a potential return to positive earnings growth after a projected slight decline in the next quarter.
The document summarizes a market perspectives report from February 2019. It notes that while corporate earnings continued to rebound in Q4 2018 with sales and earnings growth, concerns about future growth have emerged given global market volatility and more difficult year-over-year comparisons as companies will no longer benefit from tax cuts that boosted 2018 growth. The report analyzes recent earnings trends and expectations for slowing but continued growth in 2019, noting that earnings slowdowns do not always predict recessions and some slowing may already be priced into market expectations given valuation levels.
The document provides an equity market update for January 2019. It summarizes macroeconomic indicators for India and globally. For India, key points are GDP growth slowed in the second quarter, while inflation based on IIP and WPI increased. Domestic equity markets ended 2018 flat. The document recommends that investors continue investing in equity schemes, but also consider asset allocation funds given potential volatility around elections. It provides recommendations for both pure equity and balanced funds.
Multiple factors are leading to increase in demand for ventilators. Some of the include increased focus on intensive care and rapidly rising population of geriatric population worldwide. To compound the situation further is increase in chronic diseases. As the world sees failing health owing to lifestyle changes and demographics shift, market for ventilators chart an upward growth.
Uncertainty in financial markets continued in the fourth quarter of 2018, with major stock market indices experiencing sharply negative returns. International markets fared better than US markets in the fourth quarter but posted negative returns for the full year in local and US dollar terms. Fixed income markets also experienced losses, though returns were mixed, as central banks raised interest rates. Looking ahead, uncertainty remains high given concerns around trade wars, economic growth, corporate earnings, and monetary policy.
4th Quarter Stock Market Recap and 2020 OutlookMatthewFox96
Here is our 4th Quarter Stock Market Recap and 2020 Outlook. We discuss the difference between 12 month and 15 month market performance, stock market valuations, the market showing resiliency in the face of many recessionary signals that flashed in 2019, and more. Also don't miss our possible 2020 S&P 500 price targets!
Swiss Re sigma 3/2019: World insurance: the great pivot east continuesΔρ. Γιώργος K. Κασάπης
Global insurance premium volumes passed a new benchmark high of USD 5 trillion in 2018. Global life premium growth was weak, but there was solid performance in non-life in 2018.
The central narrative of this year's annual world insurance sigma is the continued rise of the emerging markets, mostly emerging Asia and China in particular, as the main drivers of industry growth. From 11% in 2018, China's share of global premiums will rise to 20% by 2029. China remains on course to become the world's biggest insurance market by mid-2030s. The whole of Asia-Pacific will account for 42% of the global premiums by 2029.
Swiss Re Institute forecasts close to 3% global premium growth in real terms per annum in 2019/20, against a slowing but still positive economic backdrop. Advanced market premiums will grow by 1.5%, and emerging markets by 7.9%. China will be the largest contributor, in both life and non-life. Overall, however, the advanced markets will still provide almost half of additional premiums in absolute terms in the next two years.
The document provides a weekly summary of news related to Balmer Lawrie and other public sector enterprises (PSEs) in India. It includes articles discussing India's slowing GDP growth rate according to the IMF, rising retail inflation in India to 3.21% in August, growth in India's industrial production to 4.3% in July, and India's exports declining 6% in August while the trade deficit narrowed. It also covers updates on the government's plans to accelerate the strategic sale of PSEs to meet disinvestment targets and potential companies that may be privatized, including BPCL.
StartUp Health Insights Global Digital Health Funding Report Q3 2018StartUp Health
A new benchmark has been set in the digital health market in Q3 2018, surpassing 2017 Q3 funding by almost $2B, hitting an all
time high Q3 mark of $11.1B. Record numbers of mid- and late-stage deals serve as a stabilizing force, creating market maturity
parallel to fund growth. International investments surge with Beijing as the home of five of the top ten international deals, and
European cities serving up an abundance of early-stage deals. With investors outpacing their 2017 totals, the digital health
market continues to be one of the fastest growing segments of the healthcare industry.
The document provides an overview and analysis of the current state of the markets in June 2018. It summarizes that while earnings growth remains strong, expectations are that growth may be peaking. It also notes that interest rates have risen and volatility has normalized this year after an unusually low-volatility 2017. The conclusion is that the market environment is normalizing, which should create continued volatility, so investors need flexibility to capitalize on opportunities.
The market volatility of late summer seemed to fade as markets hit new highs in November due to optimism around a trade deal and accommodative monetary policy. While overall earnings declined slightly in Q3 due to weaknesses in energy, materials, and tech, most companies still saw sales growth and expressed a positive outlook. Larger companies have seen stronger earnings growth. The Treasury yield curve flattened again in November after widening for months, which bears watching given past recessions have followed yield curve inversions. Most analysts anticipate an earnings recovery in coming quarters but will monitor trends closely given high market valuations.
- The document discusses Indonesia's economic and fiscal updates under President Joko Widodo's 2019-2024 vision of improving connectivity and infrastructure. Key points include GDP growth slowing to a 2-year low of 5.05% in Q2 2019 due to weaker investment. Exports fell while imports declined faster, helping GDP. The US-China trade war has boosted Vietnam's economy but widened Indonesia's trade deficit. Solutions proposed include improving competitiveness, workforce skills, and commodity value-addition. The DGT outlines new tax regulations like tax holidays and super deductions to promote investment and employment.
The document summarizes a market perspectives report from May 2019. It discusses the Q1 2019 corporate earnings season, which saw 76% of S&P 500 companies beat earnings expectations. While earnings growth was positive, companies relying more on international revenue saw declines as trade tensions increased global economic uncertainty. Looking forward, progress in US-China trade talks will be important for continued optimism, as earnings disruptions may occur if disputes persist.
The 2nd quarter of 2018 saw continued strong earnings growth in the S&P 500, with sales up 10% and earnings up over 25%. All eleven sectors showed positive year-over-year growth and most companies signaled optimism for the remainder of the year. The strong earnings beat even the fairly aggressive expectations heading into the quarter. Additionally, recent economic stimulus has led to surging GDP growth and a strong job market with low unemployment, despite concerns over trade and currencies. Barring unforeseen geopolitical impacts, growth is expected to remain robust through the end of 2018.
This document provides a weekly media update from Balmer Lawrie with news clips from September 3, 2018 related to the Indian economy and Balmer Lawrie's business sectors. Key points include:
- The RBI expects India's GDP growth to reach 7.4% in the current fiscal year due to increased industrial activity and a good monsoon.
- GDP growth accelerated to an over two-year high of 8.2% in the first quarter of 2018-2019, driven by expansion in manufacturing, agriculture, and consumer spending.
- India is projected to become the world's fifth largest economy in 2019 by overtaking Britain.
Mercer Capital's Value Focus: Real Estate Industry | Q2 2018 | Segment Focus:...Mercer Capital
Mercer Capital's Real Estate Industry newsletter provides perspective on valuation issues. Each newsletter also typically includes a macroeconomic trends, industry trends, and guideline public company metrics.
- Healthcare venture investment declined as a percentage of total venture dollars but remained strong at $6.7 billion in 2013, driven by IPO activity and later-stage financing rounds.
- Venture fundraising stabilized around $3.5-4 billion annually, maintaining a healthy level of funding for innovation. Investment is expected to decline slightly to $5-5.5 billion as IPO activity cools.
- Biopharma saw increased corporate venture participation in Series A financings, bolstering early-stage funding levels. Device Series A investment remained low due to less overall funding and focus on later stages.
2018 StartUp Health Insights Global Digital Health Funding Report 2018 MidyearStartUp Health
The first half of 2018 has brought an increase in deal volume and a total of $6.1B invested in digital health companies across the globe - showing a heightened confidence in the sector.
Similar to 2019 Healthcare and Life Sciences Outlook for India : Business Today, Kapil Khandelwal, www.kapilkhandelwal.com (20)
ONDC aims to democratize digital commerce in India by creating an open network for inclusive and competitive marketplaces. It seeks to eliminate barriers that currently constrain digital commerce, which accounts for only 7% of total retail. ONDC is a Section 8 company led by a dedicated team and advisory council. It has been working since 2020 to digitally support small retailers and include them equally alongside large sellers. The network will exponentially increase options for buyers at multiple price points across India.
The document provides an overview of the ConsumerTech landscape in India. It discusses key trends shaping the space such as the democratization of online commerce, the increasing relevance of omni-channel, social media and marketplaces becoming important search sites, the rise of quick commerce, and shifting consumer preferences. The summary also outlines challenges and opportunities for companies in India, including scaling startups from 0-10 and driving sustainable growth from 10-100. The ConsumerTech sector in India has seen significant value creation with $250Bn in valuation and over 40 unicorns.
the foreword written by Brad Smith for Microsoft’s report Governing AI: A Blueprint for India. The first part of the report details five ways India could consider policies, laws, and regulations around AI. The second part focuses on Microsoft’s internal commitment to ethical AI, showing how the company is both operationalizing and building a culture of responsible AI. The final part shares case studies from India demonstrating how AI is already helping address major societal issues in the country.
The AI Index Report 2023 provides the following key highlights from its research and development chapter:
1. The US and China have the most cross-country AI research collaborations, though the rate of growth has slowed in recent years.
2. Global AI research output has more than doubled since 2010, led by areas like machine learning, computer vision and pattern recognition.
3. China now leads in total AI research publications, while the US still leads in conference and repository citations but these leads are decreasing.
4. Industry now produces far more significant AI models than academia, as building state-of-the-art systems requires greater resources that industry can provide.
5. Large language models
The document discusses the economic potential of generative AI. Some key points:
- Generative AI could add $2.6-$4.4 trillion annually to the global economy by automating tasks across various industries and business functions. This would increase AI's total economic impact by 15-40%.
- About 75% of the value from generative AI would come from use cases in customer operations, marketing/sales, software engineering, and research & development.
- All industry sectors would be significantly impacted, including banking, high tech, and life sciences. Banking alone could see $200-$340 billion in additional annual value from generative AI use cases.
The document outlines India's reforms to open up its space sector to private companies. It discusses the need for reforms due to growth in the global space economy dominated by private companies. The reforms aim to enable private sector participation through policies like allowing them to launch their own rockets and satellites, and utilize ISRO facilities. A key part of reforms is setting up IN-SPACe as the regulator and interface between private companies and ISRO. The reforms have received overwhelming response from private sector and are expected to boost growth of India's space industry and economy.
This document is the introduction chapter of the 2022 World Happiness Report. It provides an overview of the past 10 years of happiness research and the World Happiness Report. Some key points:
- Interest in measuring national well-being and happiness has grown significantly in recent years, with policymakers seeing it as an important development objective.
- Global average life evaluations have remained relatively stable over the past decade, but there is large variability between countries, with some nations experiencing large increases or decreases.
- The 2022 report explores trends in emotions, well-being, and social connections during the COVID-19 pandemic using new data sources like social media.
- The introduction thanks the many contributors to happiness research
This document is a working paper that studies the overstatement of GDP growth in autocratic regimes compared to democracies. The author uses nighttime light data from satellites as a proxy for economic activity that is less prone to manipulation than GDP figures reported by governments. Regression analyses show that the elasticity of GDP to changes in nighttime lights is systematically higher in more authoritarian countries, suggesting autocracies exaggerate yearly GDP growth by about 35%. This paper aims to provide more credible estimates of economic performance in non-democratic countries.
Toro Finserve, led by healthcare industry veteran Kapil Khandelwal, has launched a $1 billion healthcare impact fund. The fund has received commitments from global hedge funds and domestic healthcare players. It will provide non-equity funding of up to 9 years to healthcare companies that have been stalled or declared non-performing assets by lenders. Most investments will focus on accelerating digital healthcare adoption, even in smaller towns where access remains limited. The first investment is planned in the next 3-4 months.
India Investment: Returning hope for healthcare and life sciences in the year...Kapil Khandelwal (KK)
Kapil Khanelwal KK article in CNBC-TV18 on investing in 2023 in Healthcare and Lifesciences in India
QuoteUnquote with KK
Kapil Khandelwal KK
Toro Finserve LLP
The document summarizes the investment outlook for the Indian healthcare and lifesciences sector in 2023 according to Kapil Khandelwal of Toro Finserve and EquNev Capital. It predicts a moderate outlook overall as healthcare spending falls due to high inflation and slow economic growth. Digitalization will continue but health data regulation will tighten. Some segments like healthcare insurance are predicted to be "hot" while others like providers and health retail will see margin pressures. The document outlines factors that could positively or negatively impact investment across various industry segments in 2023.
QuoteUnquote with KK 2023 Season 4 is all about ‘Growing Positively’Kapil Khandelwal (KK)
QuoteUnquote with KK 2023 Season 4 is all about ‘Growing Positively’
Announcement of 2023 Season 4 by QuoteUnquote with KK
Kapil Khandelwal KK
QuoteUnquote with KK
www.kapilkhandelwal.com
The document discusses India's economic opportunities for foreign investors over the next few years. It makes three key points:
1) India is projected to have the highest GDP growth in USD terms of any major economy in FY23 and through FY27 according to IMF estimates, presenting major opportunities for investors.
2) India's macroeconomic fundamentals are stronger than before the pandemic, as policies focused on both supply-side and demand-side measures to boost output while controlling inflation. This makes an economic crisis unlikely.
3) Looking forward, factors like recovering corporate profits, financial sector reforms, a focus on manufacturing growth, and strengthening of the banking sector point to India avoiding long-term economic scarring from
QuoteUnquote with KK (Kapil Khandelwal) Season 2 premiers as the first podcas...Kapil Khandelwal (KK)
New on afaqs! on QuoteUnquote with KK (Kapil Khandelwal) Season 2 premiers as the first podcast on Dailyhunt
www.kapilkhandelwal.com
QuoteUnquote with KK
Zee5 Hosts ‘QuoteUnQuote with KK’ Podcast As Exclusive Content On Their News ...Kapil Khandelwal (KK)
Zee5 has announced that it will host the podcast "QuoteUnquote with KK" exclusively on its news section. The monthly podcast features conversations between Kapil Khandelwal and thought leaders from around the world on topics like business, economics, investing, and sociopolitics. Popular episodes include discussions on India's economic recovery, the future of healthcare and capital markets, and China's Belt and Road initiative. The podcast aims to provide an outsider's perspective on issues in India and will now be available to Zee5's large audience.
Where is the vision? : Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that discusses the Bangalore India Bio and its outcomes
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
The bridge to education: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that is discussing issues around ICT in health education
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesHolger Mueller
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
3 Simple Steps To Buy Verified Payoneer Account In 2024SEOSMMEARTH
Buy Verified Payoneer Account: Quick and Secure Way to Receive Payments
Buy Verified Payoneer Account With 100% secure documents, [ USA, UK, CA ]. Are you looking for a reliable and safe way to receive payments online? Then you need buy verified Payoneer account ! Payoneer is a global payment platform that allows businesses and individuals to send and receive money in over 200 countries.
If You Want To More Information just Contact Now:
Skype: SEOSMMEARTH
Telegram: @seosmmearth
Gmail: seosmmearth@gmail.com
Company Valuation webinar series - Tuesday, 4 June 2024FelixPerez547899
This session provided an update as to the latest valuation data in the UK and then delved into a discussion on the upcoming election and the impacts on valuation. We finished, as always with a Q&A
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Best practices for project execution and deliveryCLIVE MINCHIN
A select set of project management best practices to keep your project on-track, on-cost and aligned to scope. Many firms have don't have the necessary skills, diligence, methods and oversight of their projects; this leads to slippage, higher costs and longer timeframes. Often firms have a history of projects that simply failed to move the needle. These best practices will help your firm avoid these pitfalls but they require fortitude to apply.
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
buy old yahoo accounts buy yahoo accountsSusan Laney
As a business owner, I understand the importance of having a strong online presence and leveraging various digital platforms to reach and engage with your target audience. One often overlooked yet highly valuable asset in this regard is the humble Yahoo account. While many may perceive Yahoo as a relic of the past, the truth is that these accounts still hold immense potential for businesses of all sizes.
Structural Design Process: Step-by-Step Guide for BuildingsChandresh Chudasama
The structural design process is explained: Follow our step-by-step guide to understand building design intricacies and ensure structural integrity. Learn how to build wonderful buildings with the help of our detailed information. Learn how to create structures with durability and reliability and also gain insights on ways of managing structures.
2019 Healthcare and Life Sciences Outlook for India : Business Today, Kapil Khandelwal, www.kapilkhandelwal.com
1. Print Close
Healthcare and Life Sciences outlook 2019: Is
the heat still on?
Kapil Khandelwal January 2, 2019
The year 2018 started with a bang and a positive outlook on healthcare and life sciences
sector. While in US, the S&P 500 Healthcare index outperformed to add nearly 5 per cent
versus 6.23 per cent fall in broader S&P 500 in 2018.
Closer home, BSE Healthcare Index underperformed losing 6 per cent versus 6 per cent
gains on Sensex during the year. These are just broader market indices and public market
indicators of investment activity in healthcare and life sciences sector. The other side of
the coin has private markets. The activity there remained subdued in terms of number of
deals and investments in Q3FY18. This is because older post Lehman Era vintage is still
looking for exits. So what is the outlook for 2019?
Our investment heatmap for 2019 shows a much cautious mood across the healthcare
and life sciences sub-sectors with opportunities in some hot spaces. Is the heat still on in
2019?
As compared to the 2018 heatmap, the heatmap for 2019 has some fire being doused by
caution due to what transpired in 2018. When compared to the heatmap of 2018, the 2019
map still has some areas that will continue to remain hot for the sector on a selective
basis. The first half of 2019 will see the political heat of the general elections in India
leading to the uncertainty around investment in the sector. Largely, 2019 will be positive
socio-politically but may cause some dent on the margins and valuations of the sector.
Healthcare financing
Medical cost inflation after the rupee devaluation in 2018 and emerging price controls on
procedures and implants will continue to be in the range of 20 per cent to 24 per cent in
2019. As the 'India Stack' builds up to bring the next 500 million into its fold, the consumer
financing of healthcare events will still attract many operators leveraging fintech tools.
Innovation into financing products and services for consumer financing of healthcare will
see a few more players emerge. Incumbents of the likes of Bajaj Finserv will expect to
increase the coverage throughout India in 2019. However, subvention will be under
pressure from the healthcare operators due to margin pressures.
2019 Outlook: Very hot
What's going wrong: Regulation, maturity to scale
What's going right: India stack digitisation, consumer spending on health and wellness
Medical education
Healthcare and Life Sciences outlook 2019: Is the heat still on? : Business Today Page 1 of 4
https://www.businesstoday.in/storyprint/306331 03-01-2019